CRH MEDICAL CORP's ticker is CRHM and the CUSIP is 12626F105. A total of 44 filers reported holding CRH MEDICAL CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $84,000 | -61.3% | 63,689 | +1.9% | 0.00% | – |
Q4 2019 | $217,000 | +11.9% | 62,529 | -0.9% | 0.00% | – |
Q3 2019 | $194,000 | -16.0% | 63,073 | -17.9% | 0.00% | – |
Q2 2019 | $231,000 | -10.5% | 76,778 | -21.3% | 0.00% | – |
Q1 2019 | $258,000 | -18.6% | 97,593 | -5.8% | 0.00% | -100.0% |
Q4 2018 | $317,000 | -26.1% | 103,605 | -3.9% | 0.00% | 0.0% |
Q3 2018 | $429,000 | +25.1% | 107,838 | -1.7% | 0.00% | 0.0% |
Q2 2018 | $343,000 | +27.5% | 109,756 | +3.1% | 0.00% | – |
Q1 2018 | $269,000 | +1.1% | 106,423 | +5.6% | 0.00% | – |
Q4 2017 | $266,000 | -8.0% | 100,746 | -9.3% | 0.00% | – |
Q3 2017 | $289,000 | -24.3% | 111,054 | +65.3% | 0.00% | -100.0% |
Q2 2017 | $382,000 | +10.1% | 67,203 | +57.7% | 0.00% | 0.0% |
Q1 2017 | $347,000 | +64.5% | 42,607 | +7.9% | 0.00% | – |
Q4 2016 | $211,000 | +129.3% | 39,483 | +65.9% | 0.00% | – |
Q3 2016 | $92,000 | +29.6% | 23,800 | +10.4% | 0.00% | – |
Q1 2016 | $71,000 | +115.2% | 21,552 | +92.8% | 0.00% | – |
Q4 2015 | $33,000 | – | 11,181 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STADIUM CAPITAL MANAGEMENT LLC | 2,182,483 | $6,657,000 | 2.76% |
Pacific Ridge Capital Partners, LLC | 1,839,473 | $5,610,000 | 1.87% |
Nantahala Capital Management | 6,534,155 | $20,028,000 | 0.62% |
Beutel, Goodman & Co Ltd. | 5,127,100 | $15,703,000 | 0.13% |
PALLADIUM PARTNERS LLC | 207,900 | $634,000 | 0.05% |
Connor, Clark & Lunn Investment Management Ltd. | 2,201,799 | $6,739,000 | 0.05% |
Spark Investment Management LLC | 172,000 | $527,000 | 0.04% |
SEIZERT CAPITAL PARTNERS, LLC | 170,842 | $521,000 | 0.02% |
Sepio Capital, LP | 97,844 | $298,000 | 0.02% |
STIFEL FINANCIAL CORP | 2,116,607 | $6,459,000 | 0.02% |